Case Conference (December 2, 2020)

This Citywide Infectious Diseases Conference will take place on Wednesday, December 2, 2020 at 12:00 P.M. Attendance for this conference will only be available through Zoom.

CME Information

Needs Statement

Infectious diseases faculty, fellows, residents, medical students, and pharmacists who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the field of infectious disease, including hospital-acquired infections, antimicrobial resistance, infections related to chemotherapy and immunomodulators, and travel-acquired infections. The conference aims to increase clinical knowledge of the learners in these topic areas, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.

Objectives

At the conclusion of the sessions, the participants should be able to:

  • Summarize types of infections associated with specific chemotherapy and immune modulator therapies.
  • Identify different etiologies and treatments of hospital-acquired infections.
  • Review antimicrobial patterns of resistance and identify treatment for multi-drug resistant infections.
  • Develop a differential diagnosis for returning travelers who present with fever.

Target Audience

  • Physicians
  • Medical Students
  • Fellows
  • Residents
  • Other Health Professionals

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Program Director

  1. Jose Serpa-Alvarez, M.D., M.S.

    Jose Serpa-Alvarez, M.D., M.S.

    Associate Professor
    Baylor College of Medicine

Disclosure Policy

The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.

Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.

If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.

Disclosures

The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:

Presenters

  1. Zain Alamarat, M.D.

    Zain Alamarat, M.D.

    Pediatric Infectious Diseases Fellow
    University of Texas Health Science Center at Houston

    Disclosure:

    Nothing to disclose.

  2. Taryn Eubank, PharmD

    Taryn Eubank, PharmD

    Clinical Resident
    Methodist Hospital Houston

    Disclosure:

    Nothing to disclose.

  3. Alexander Franklin, M.D.

    Alexander Franklin, M.D.

    Infectious Diseases Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Program Director

  1. Jose Serpa-Alvarez, M.D., M.S.

    Jose Serpa-Alvarez, M.D., M.S.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

Planning Committee Members

  1. Robert Atmar, M.D.

    Robert Atmar, M.D.

    John S. Dunn Research Foundation Clinical Professorship in Infectious Diseases Honoring Temple W. Williams, Jr., M.D.
    Baylor College of Medicine

    Disclosure:
    • Research Support: Takeda Vaccines, Inc.
    • Advisory Committee Membership: Seres Therapeutics
  2. Charles Ericsson, M.D.

    Charles Ericsson, M.D.

    Professor
    University of Texas Health Science Center at Houston

    Disclosure:

    Nothing to disclose.

  3. Emmanuel Guajardo, M.D. Placeholder Image

    Emmanuel Guajardo, M.D.

    Clinical Postdoctoral Fellow
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  4. Daniel Musher, M.D.

    Daniel Musher, M.D.

    Distinguished Service Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

  5. Jose Serpa-Alvarez, M.D., M.S.

    Jose Serpa-Alvarez, M.D., M.S.

    Associate Professor
    Baylor College of Medicine

    Disclosure:

    Nothing to disclose.

CME Credit Available

You may claim CME credit after watching this activity.

View the CME Information

Presenters:

  1. Zain Alamarat, M.D.

    Zain Alamarat, M.D.

    Pediatric Infectious Diseases Fellow University of Texas Health Science Center at Houston
  2. Taryn Eubank, PharmD

    Taryn Eubank, PharmD

    Clinical Resident Methodist Hospital Houston
  3. Alexander Franklin, M.D.

    Alexander Franklin, M.D.

    Infectious Diseases Fellow Baylor College of Medicine